CCXIU — Churchill Capital XI Share News
0.000.00%
Last trade - 00:00- $632.20m
- $630.94m
Brief: ChemoCentryx Inc Announces FDA Approval Of Tavneos (AVACOPAN)
U.S. FDA approves ChemoCentryx drug to treat rare autoimmune disease
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
U.S. RESEARCH ROUNDUP- Blade Air Mobility, Travel + Leisure, Vail Resorts
Brief: ChemoCentryx Inc Announces Approval In Japan Of Tavneos (Avacopan)
U.S. RESEARCH ROUNDUP-Dollar General, Guild Holdings, Workday
ChemoCentryx Inc reports results for the quarter ended in June - Earnings Summary
ChemoCentryx Inc expected to post a loss of 55 cents a share - Earnings Preview
ChemoCentryx gains after filing amendment to application for Avocopan
Brief: ChemoCentryx Reports Filing of Amendment to NDA Submission and Extension of PDUFA Review Period for Avacopan
U.S. STOCKS ON THE MOVE-Gannett, Centerra Gold, Bill.com Holdings
U.S. STOCKS ON THE MOVE-Acasti Pharma, Roku, Centerra Gold
U.S. STOCKS ON THE MOVE-Peloton, ChemoCentryx, F-star Therapeutics
ChemoCentryx: Slumps on FDA panel's mixed opinion on approval for co's lead drug
NASDAQ RESUMED AT 07:10 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
U.S. RESEARCH ROUNDUP-Albemarle, Seaworld Entertainment, Treehouse Foods
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
ChemoCentryx: Slumps after FDA staff raises concerns over lead drug